Dr. Quynh-Thu Le, MD

Radiation Oncologist

Stanford, CA

26 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

Who is Dr. Le, Radiation Oncologist in Stanford, CA?

Dr. Quynh-Thu Le, MD is a Radiation Oncologist, who primarily practices in Stanford, CA with 1 additional practice location. She has been practicing for over 26 years and is board certified by the American Board of Radiology. Dr. Le graduated from University of California and completed her residency at Univ Ca Sf Sch Of Med, Radiation Oncology; Alameda Co Med Ctr, Flexible Or Transitional Year. Dr. Le is fluent in English and Vietnamese, and is currently seeing new patients. Dr. Le’s practice accepts Medicaid, Medicare, UnitedHealthcare, Aetna and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Le’s office at (650) 723-4000.

What are Areas of Expertise for Dr. Le?

Dr. Quynh-Thu Le, MD is a highly-rated, board-certified Radiation Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Le empowers patients to confidently navigate their health journey, specializing in Clinical Trials, Head & Neck Cancer, Lung Cancer, Thoracic Cancers, or comprehensive wellness support. Serving the Stanford/CA community, Dr. Le is dedicated to enhancing lives through expert, patient-centered care.

Where did Dr. Le go to medical school and complete their residency?

Residency: Univ Ca Sf Sch Of Med, Radiation Oncology; Alameda Co Med Ctr, Flexible Or Transitional Year | UCSF Medical Center | University of California, San Francisco
Medical School: University of Ca, San Francisco, Sch of Med, San Francisco Ca | University of California

Is Dr. Le board certified in Radiation Oncologist?

Yes, Dr. Quynh-Thu Le, MD is board certified by the American Board of Radiology , American Board of Radiology since 1998

What languages does Dr. Le speak?

Dr. Le and their clinical team can communicate with patients in the following languages:

English
Vietnamese

What conditions does Dr. Le treat?

As a Radiation Oncologist, Dr. Le diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Le. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.

Also known as:

Throat Cancer
Oral Cancer
Tonsil Cancer
Oropharyngeal Cancer
Malignant Neoplasm of Tonsil
Nasopharyngeal Cancer
Malignant Neoplasm of Nasopharynx
Pharyngeal Cancer
Malignant Neoplasm of Oropharynx
Laryngeal Cancer
Voice Box Cancer
Malignant Laryngeal Tumor

ICD-10 Codes:

C099: Malignant neoplasm of tonsil, unspecified
C119: Malignant neoplasm of nasopharynx, unspecified
C109: Malignant neoplasm of oropharynx, unspecified
C329: Malignant neoplasm of larynx, unspecified

Also known as:

Oral Cancer
Mouth Cancer
Tongue Cancer
Oral Cavity Cancer
Tongue Carcinoma
Malignant Neoplasm of Tongue
Mouth Malignancy
Oral Carcinoma

ICD-10 Codes:

C01: Malignant neoplasm of base of tongue
C029: Malignant neoplasm of tongue, unspecified
C069: Malignant neoplasm of mouth, unspecified

Also known as:

Nasal Cancer
Sinus Cancer
Head and Neck Cancer
Nasal Cavity Cancer
Nose Cancer
Malignant Nasal Tumor
Maxillary sinus cancer
Nasal sinus cancer
Malignant neoplasm of maxillary sinus
Head Cancer
Neck Cancer
Facial Cancer
Malignant Head and Neck Tumor

ICD-10 Codes:

C300: Malignant neoplasm of nasal cavity
C310: Malignant neoplasm of maxillary sinus
C760: Malignant neoplasm of head, face and neck

Also known as:

Secondary Cancer in Head and Neck Lymph Nodes
Cancer
Metastatic Cancer to Neck Lymph Nodes
Head and Neck Lymph Node Cancer Spread
Lymph Node Metastasis in Neck

ICD-10 Codes:

C770: Secondary and unspecified malignant neoplasm of lymph nodes of head, face and neck

Also known as:

History of Radiation Therapy
Radiation Therapy
Past Radiation Treatment
Previous Radiotherapy
History of Radiotherapy

ICD-10 Codes:

Z923: Personal history of irradiation

Also known as:

Salivary Gland Cancer
Parotid Gland Cancer
Salivary Gland Tumor
Salivary Gland Carcinoma
Major Salivary Gland Cancer

ICD-10 Codes:

C07: Malignant neoplasm of parotid gland
C089: Malignant neoplasm of major salivary gland, unspecified

Also known as:

Secondary Brain Cancer
Secondary Cancer (Other Specified Sites)
Secondary Bone Cancer
Brain Tumor
Cancer
Bone Cancer
Metastatic brain cancer
Brain metastases
Cancer spread to brain
Metastatic cancer
Cancer spread to other organs
Cancer metastases
Metastatic bone cancer
Cancer spread to bone
Bone metastases

ICD-10 Codes:

C7931: Secondary malignant neoplasm of brain
C7989: Secondary malignant neoplasm of other specified sites
C7951: Secondary malignant neoplasm of bone

Also known as:

Prostate Cancer
Prostate Cancer Treatment (PDQ®)
Prostatic Carcinoma
Prostate Gland Cancer
Malignant Prostate Tumor

ICD-10 Codes:

C61: Malignant neoplasm of prostate

Also known as:

Oropharyngeal Dysphagia
Swallowing Disorder
Difficulty Swallowing in Throat
Trouble Starting to Swallow
Throat Swallowing Problems

ICD-10 Codes:

R1312: Dysphagia, oropharyngeal phase

Also known as:

Cancer Radiation Therapy
Radiation Therapy
Radiation Therapy to Treat Cancer
Radiation treatment for cancer
Oncology radiation
Radiotherapy

ICD-10 Codes:

Z510: Encounter for antineoplastic radiation therapy

Which procedures does Dr. Le perform as a Radiation Oncologist?

As a Radiation Oncologist, procedures performed by a Dr. Quynh-Thu Le may include:

For detailed information, please contact Dr. Le's office.

Does Dr. Le accept my insurance?

Dr. Le accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.

What insurance plans does Dr. Le accept in Stanford, CA?

Dr. Le in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

Top Insurances

All Other Third Party
Blue Shield of California
CVS Health (formerly Aetna)
Medicaid
Medicare
OptumRx
Santa Clara Family Health Plan
State of California
UnitedHealthcare
Valley Health Plan

View All Insurances

Where is Dr. Le's office located?

Dr. Quynh-Thu Le's Primary Practice

300 Pasteur Dr

Stanford, CA 94305

(650) 723-4000

Get Directions

Dr. Quynh-Thu Le's Practice 2

875 Blake Wilbur Dr Ste D

Palo Alto, CA 94304

Get Directions

Recognitions

Publications

Radiotherapy for nodenoid cystic carcinomas of major salivary glands.

American jourl of otolaryngology, 2013

A novel aldehyde dehydrogese-3 activator

Clinical cancer research, 2013

Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.

Intertiol jourl of radiation oncology, biology, physics, 2013

Cost-effectiveness l

Oral surgery, oral medicine, oral pathology and oral radiology, 2013

Stereotactic radiosurgery for retreatment of gross perineural invasion

American jourl of clinical oncology, 2013

Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.

Jourl of the tiol Cancer Institute, 2013

An intertiol collaboration to harmonize the quantitative plasma Epstein

Clinical cancer research, 2013

Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.

Jourl of applied clinical medical physics, 2013

CD44+cells have cancer stem cell-like properties in sopharyngeal carcinoma

INTERTIOL FORUM OF ALLERGY & RHINOLOGY, 2012

Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors

JOURL OF THORACIC ONCOLOGY, 2012

Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

Intrafraction Verification of Gated RapidArc by Using Beam-Level Kilovoltage X-Ray Images

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

Evaluation of ProExC as a Prognostic Marker in Oropharyngeal Squamous Cell Carcinomas

AMERICAN JOURL OF SURGICAL PATHOLOGY, 2012

Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

A Planned Neck Dissection Is Not Necessary in All Patients With N2-3 Head-

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

Intensity-Modulated Radiotherapy for Tumors of the sal Cavity and Parasal Sinuses

Wiegner, E. A., Daly, M. E., Murphy, J. D., Abelson, J., Chapman, C. H, 2012

Quantitation of Human Papillomavirus D in Plasma of Oropharyngeal Carcinoma Patients

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012

Addition of bevacizumab to st

LANCET ONCOLOGY, 2012

Prognostic Significance of Plasma Osteopontin in Patients with Locoregiolly Advanced Head

CLINICAL CANCER RESEARCH, 2012

Salvage Treatment for Locally Recurrent sopharyngeal Carcinoma (NPC).

American jourl of clinical oncology

A Novel Aldehyde Dehydrogese-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo

CLINICAL CANCER RESEARCH, 2011

ON-BOARD IMAGING VALIDATION OF OPTICALLY GUIDED STEREOTACTIC RADIOSURGERY POSITIONING SYSTEM FOR

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

HIGH RETENTION AND SAFETY OF PERCUTANEOUSLY IMPLANTED ENDOVASCULAR EMBOLIZATION COILS AS FIDUCIAL

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

INTENSITY-MODULATED RADIOTHERAPY FOR ORAL CAVITY SQUAMOUS CELL CARCINOMA

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head

JOURL OF CLINICAL ONCOLOGY, 2011

POSTRADIATION METABOLIC TUMOR VOLUME PREDICTS OUTCOME IN HEAD-AND-NECK CANCER

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011

Tumor Volume as a Potential Imaging-Based Risk

JOURL OF THORACIC ONCOLOGY, 2011

Glioma-Associated Oncogene Family Zinc Finger 1 Expression and Metastasis in Patients With Head and

JOURL OF CLINICAL ONCOLOGY, 2011

MYB Expression and Translocation

AMERICAN JOURL OF SURGICAL PATHOLOGY, 2011

INTENSITY-MODULATED RADIOTHERAPY FOR LOCALLY ADVANCED CANCERS OF THE LARYNX AND HYPOPHARYNX

HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2011

HIGHER INCIDENCE OF HEAD AND NECK CANCERS AMONG VIETMESE AMERICAN MEN IN CALIFORNIA

HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2010

Dose reconstruction for volumetric modulated arc therapy

PHYSICS IN MEDICINE AND BIOLOGY, 2010

The Tumor Microenvironment in Non-Small-Cell Lung Cancer

SEMIRS IN RADIATION ONCOLOGY, 2010

MiR-210-micromager of the hypoxia pathway

TRENDS IN MOLECULAR MEDICINE, 2010

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

TRANSLATIOL ONCOLOGY, 2010

INTENSITY-MODULATED RADIOTHERAPY IN THE TREATMENT OF OROPHARYNGEAL CANCER

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010

Identification of a biomarker panel using a multiplex proximity ligation

JOURL OF TRANSLATIOL MEDICINE, 2009

COMPARISON OF TREATMENT RESULTS BETWEEN ADULT AND JUVENILE SOPHARYNGEAL CARCINOMA

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

Mucositis-Related Morbidity and Resource Utilization in Head and Neck Cancer Patients Receiving

JOURL OF PAIN AND SYMPTOM MAGEMENT, 2009

Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival

JOURL OF CLINICAL ONCOLOGY, 2009

METABOLIC TUMOR VOLUME PREDICTS FOR RECURRENCE AND DEATH IN HEAD-AND-NECK CANCER

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

PET of EGFR Antibody Distribution in Head and Neck Squamous Cell Carcinoma Models

JOURL OF NUCLEAR MEDICINE, 2009

THE RELATIONSHIP BETWEEN HUMAN PAPILLOMAVIRUS STATUS AND OTHER MOLECULAR PROGNOSTIC MARKERS IN HEAD

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009

XBP-1 regulates angiogenesis in human pancreatic adenocarcinomas

TRANSLATIOL ONCOLOGY, 2009

X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas.

Translatiol oncology, 2009

Integrating Biologically Targeted Therapy in Head and Neck Squamous Cell Carcinomas

SEMIRS IN RADIATION ONCOLOGY, 2009

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small

JOURL OF CLINICAL ONCOLOGY, 2008

In vivo H-1 magnetic resonce spectroscopy of lactate in patients with Stage IV head

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

LIC-based on-board imaging feasibility and the dosimetric consequences of head roll in

MEDICAL DOSIMETRY, 2008

Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008

Quantification of motion of different thoracic locations using four-dimensiol computed tomography

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

Metabolic tumor burden predicts for disease progression and death in lung cancer

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

Expression and prognostic significance of a panel of tissue hypoxia markers in head-and

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

Longitudil evaluation of the oral mucositis weekly questionire-head and neck cancer

CANCER, 2007

Evaluation of patterns of failure

HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2007

Identifying and targeting hypoxia in head and neck cancer: A brief overview of current approaches

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007

sopharyngeal and oropharyngeal carcinomas

IMRT, IGRT, SBRT: ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF R, 2007

Clinical role of F-18-FDG PET

JOURL OF NUCLEAR MEDICINE, 2007

Plasma osteopontin is an independent prognostic marker for head and neck cancers

JOURL OF CLINICAL ONCOLOGY, 2006

Results of a phase I dose-escalation study using single

JOURL OF THORACIC ONCOLOGY, 2006

Indirect MR lymphangiography of the head and neck using conventiol gadolinium contrast

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006

A multidiscipliry approach to magement in a patient with bilateral superior sulcus non-small

CLINICAL LUNG CANCER, 2006

Advanced-staged tonsillar squamous carcinoma

HEAD AND NECK-JOURL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND N, 2006

Connective tissue growth factor

CANCER RESEARCH, 2006

Lysyl oxidase is essential for hypoxia-induced metastasis

TURE, 2006

An evaluation of tumor oxygetion

CLINICAL CANCER RESEARCH, 2006

Galectin-1: A link between tumor hypoxia and tumor immune privilege

JOURL OF CLINICAL ONCOLOGY, 2005

Identification of mitogen

MOLECULAR CANCER RESEARCH, 2005

Phase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005

A comparison study of different PCR assays in measuring circulating plasma Epstein

CLINICAL CANCER RESEARCH, 2005

A noninvasive approach for assessing tumor hypoxia in xenografts

CANCER RESEARCH, 2005

Phase II double-blind r

INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004

Long-Term Outcomes of Surgery Followed by Radiation Therapy for Minor Salivary Gland Carcinomas

LARYNGOSCOPE, 2013

Clinical impact of dose overestimation by effective path length calculation

Practical radiation oncology, 2013

Radiotherapy for nonadenoid cystic carcinomas of major salivary glands.

American journal of otolaryngology, 2013

A novel aldehyde dehydrogenase-3 activator

Clinical cancer research, 2013

Low-dose radiation therapy (2 Gy × 2) in the treatment of orbital lymphoma.

International journal of radiation oncology, biology, physics, 2013

Cost-effectiveness l

Oral surgery, oral medicine, oral pathology and oral radiology, 2013

Stereotactic radiosurgery for retreatment of gross perineural invasion

American journal of clinical oncology, 2013

Opportunities and challenges in the era of molecularly targeted agents and radiation therapy.

Journal of the National Cancer Institute, 2013

An international collaboration to harmonize the quantitative plasma Epstein

Clinical cancer research, 2013

Impact of positron emission tomography

CANCER, 2013

Volumetric-Modulated Arc Radiotherapy for Skull-Base and Non-Skull-Base Head and Neck Cancer

TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013

Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy.

Journal of applied clinical medical physics, 2013

Loss of the p53/p63 target PERP

Oral surgery, oral medicine, oral pathology and oral radiology, 2013

Metabolic imaging metrics correlate with survival

Lung cancer, 2012

CD44+cells have cancer stem cell-like properties in nasopharyngeal carcinoma

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2012

Esophageal tolerance to high-dose stereotactic ablative radiotherapy

DISEASES OF THE ESOPHAGUS, 2012

Stereotactic Ablative Radiotherapy for Reirradiation of Locally Recurrent Lung Tumors

JOURNAL OF THORACIC ONCOLOGY, 2012

Tumor Volume-Adapted Dosing in Stereotactic Ablative Radiotherapy of Lung Tumors